Who’s Winning the Intense Battle to Rule the White-Hot GLP-1 Drug Market?
Eli Lilly’s GLP-1 drug is now the world’s best-selling drug. Novo Nordisk is struggling with declining market share.…
Why Weight-Loss Drug Prices Are Falling| Business News
President Trump claimed credit Thursday for cutting prices on popular weight-loss drugs by Eli Lilly and Novo Nordisk.…
Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo Nordisk
When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…
Massive sales for weight loss drugs spur Eli Lilly’s Q3
As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…
Eli Lilly says weight-loss pill a candidate for speedy approval under new US program
By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
These 3 Beaten-Down Healthcare Stocks Could Have Farther to Fall
Moderna could tumble once again, if there’s a lack of positive news in its upcoming earnings release. Novo…
Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
3 Top Healthcare Stocks to Buy in October
Novo Nordisk could get its momentum back with its oral Wegovy pill. Danaher is a proven market-beater trading…
Exclusive-Bill Gates, PAHO consider ways to bring weight-loss drugs to lower-income countries
By Jennifer Rigby LONDON (Reuters) -The Gates Foundation and the Pan American Health Organization are both working on…
50 European corporates backing startups on the path to growth, innovation, and global impact
Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
Fat-loss drug Mounjaro now India’s No. 2 pharma brand | India News
NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma…